Your session is about to expire
← Back to Search
Robot Therapy for Stroke
Study Summary
This trial tests the feasibility of using an affordable robot for rehabilitation therapy for people with HIV who have experienced a stroke.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 1 & 2 trial • 59 Patients • NCT01253018Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to understand and give consent for treatment.You have severe depression according to a specific test called Becks Depression Inventory-Fast Screener.I had a stroke at least 3 months ago and am over 18.I have total paralysis or cannot move my arms or legs due to stiffness.My muscle stiffness is severe in certain areas.I have had a brain injury or damage to my cerebellum or brain stem.My pain level is more than 4 on a scale of 0 to 10.You need to have pretty good thinking and memory skills according to a specific test.I have open wounds on my arms or legs.You have a history of mental health issues or heart problems.Your neurological function, as measured by the NIH Stroke Scale, falls between 5 and 24.
- Group 1: Stroke survivors
- Group 2: Low-to-mid functioning HIV/AIDS patients
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an opportunity to join this scientific experiment?
"This clinical trial requires 30 stroke patients with ages ranging from 18 to 90. Essential requirements include a diagnosis of Stroke (at least 3 months post incident) with or without HIV, an NIHSS score between 5 and 24, moderate cognitive function as defined by the International HIV-Dementia Scale, medical stability sufficient for participation in therapy, and consenting capacity."
Does this experiment currently admit new participants?
"According to the details on clinicaltrials.gov, this research is actively enrolling participants. The trail was initially published on October 1st 2019 and has been revised as recently as December 1st 2022."
Does the eligibility criteria for this study encompass individuals under 20 years of age?
"As per this clinical trial's admittance requirements, the minimum age of recruitment is 18 years old and the maximum permissible age is 90."
Share this study with friends
Copy Link
Messenger